Skip to content

MOLN

Molecular Partners AG

NASDAQ · Healthcare · Biotechnology · CH

$3.20
+3.40%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue——5.0M7.0M189.6M
Cost of Revenue10.6M2.0M47.5M47.8M50.7M
Gross Profit(10.6M)(2.0M)(42.5M)(40.8M)138.8M
Operating Expenses
R&D Expense29.3M40.2M48.6M48.8M50.7M
SG&A Expense15.5M14.9M17.2M19.0M21.8M
General & Admin Expense—14.9M17.2M19.0M21.8M
Selling & Marketing Expense—————
Other Expenses(459.3K)(4.2M)(47.1M)(47.5M)372.0K
Total Operating Expenses44.3M50.9M18.7M20.3M72.9M
Cost and Expenses54.9M58.1M66.2M68.1M72.9M
Operating Income (EBIT)(54.9M)(58.1M)(61.2M)(61.1M)116.6M
Non-Operating
Interest Income526.5K1.5M3.4M4.3M1.2M
Interest Expense36.9K18.0K25.0K49.0K648.1K
Net Interest Income489.5K1.5M3.3M4.2M547.6K
Other Non-Op Income/Expense708.2K(3.5M)7.2M(876.0K)1.2M
Non-Operating Income (excl Interest)(683.0K)3.5M(7.2M)842.0K(1.8M)
EBT (Pre-Tax Income)(54.2M)(61.6M)(54.0M)(62.0M)117.9M
Income Tax Expense5.0K2.0K2.0K——
Bottom Line
Net Income(54.2M)(61.7M)(54.0M)(62.0M)117.9M
Earnings from Cont. Ops(54.2M)(61.7M)(54.0M)(62.0M)117.9M
Earnings from Discont. Ops—————
Bottom Line Net Income(54.2M)(61.7M)(54.0M)(62.0M)117.9M
Per Share
Basic EPS($1.34)($1.65)($1.59)($1.89)$3.63
Diluted EPS($1.34)($1.65)($1.59)($1.89)$3.54
Revenue Per Share$0.00$0.00$0.15$0.21$5.84
Shares
Basic Shares Outstanding38.3M37.3M34.0M32.8M32.5M
Diluted Shares Outstanding38.3M37.3M34.0M32.8M33.3M
Profitability Metrics
EBITDA(52.1M)(59.5M)(51.6M)(59.5M)119.0M
D&A2.1M2.1M2.4M2.4M2.4M
EBIT(54.2M)(61.6M)(54.0M)(62.0M)116.6M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026